- call +1-201-465-4211
- email sales@mrinsights.biz
Governments and various animal health institutions spread awareness about the need for good healthy diets and health supplements for the growth and healthy life of the horses among the horse breeders and trainers in various equine industries. Moreover, they provide information and awareness about the need for prevention of certain diseases and the remedy for some medical conditions. Increasing awareness about equine pharmaceuticals and supplements products is driving the growth of the global equine pharmaceuticals and supplements market. Demand for herbal digestive, feed, and energy supplements for horses are increasing due to the preference among horse breeders and trainers for natural products and it is expected to drive the growth of the pharmaceuticals and supplements market. The horseracing and equestrian sectors drive the demand for equine pharmaceutical products, as the health of the horses are very important for sustaining the growth of those sectors. Healthy horses in these sectors provide the impetus for the betting and gambling industries related to horse racing. Therefore, most of the trainers and breeders of horses adopt advanced pharmaceutical products for preventing illnesses and for healing the diseases, so that the horses are in good shape for the races.
Scope of the Report:
This report focuses on the Equine Pharmaceuticals and Supplements in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Equine Pharmaceuticals and Supplements is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Affymetrix
Bayer Animal Health
Boehringer Ingelheim
Celltrion Inc
Elanco Animal Health
Merck Animal Health
Merial
Novartis Animal Health
Vetoquinol
Zoetis
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Pharmaceuticals
Supplements
Market Segment by Applications, can be divided into
Veterinary Hospitals
Drug Stores
Others
There are 15 Chapters to deeply display the global Equine Pharmaceuticals and Supplements market.
Chapter 1, to describe Equine Pharmaceuticals and Supplements Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Equine Pharmaceuticals and Supplements, with sales, revenue, and price of Equine Pharmaceuticals and Supplements, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Equine Pharmaceuticals and Supplements, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Equine Pharmaceuticals and Supplements market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Equine Pharmaceuticals and Supplements sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Equine Pharmaceuticals and Supplements Introduction
1.2 Market Analysis by Type
1.2.1 Pharmaceuticals
1.2.2 Supplements
1.3 Market Analysis by Applications
1.3.1 Veterinary Hospitals
1.3.2 Drug Stores
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Affymetrix
2.1.1 Business Overview
2.1.2 Equine Pharmaceuticals and Supplements Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Affymetrix Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bayer Animal Health
2.2.1 Business Overview
2.2.2 Equine Pharmaceuticals and Supplements Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Boehringer Ingelheim
2.3.1 Business Overview
2.3.2 Equine Pharmaceuticals and Supplements Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Celltrion Inc
2.4.1 Business Overview
2.4.2 Equine Pharmaceuticals and Supplements Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Celltrion Inc Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Elanco Animal Health
2.5.1 Business Overview
2.5.2 Equine Pharmaceuticals and Supplements Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Merck Animal Health
2.6.1 Business Overview
2.6.2 Equine Pharmaceuticals and Supplements Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merial
2.7.1 Business Overview
2.7.2 Equine Pharmaceuticals and Supplements Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merial Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novartis Animal Health
2.8.1 Business Overview
2.8.2 Equine Pharmaceuticals and Supplements Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novartis Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Vetoquinol
2.9.1 Business Overview
2.9.2 Equine Pharmaceuticals and Supplements Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Zoetis
2.10.1 Business Overview
2.10.2 Equine Pharmaceuticals and Supplements Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Equine Pharmaceuticals and Supplements Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Equine Pharmaceuticals and Supplements Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Equine Pharmaceuticals and Supplements Manufacturer Market Share in 2017
3.3.2 Top 6 Equine Pharmaceuticals and Supplements Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Equine Pharmaceuticals and Supplements Market Analysis by Regions
4.1 Global Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Regions
4.1.1 Global Equine Pharmaceuticals and Supplements Sales and Market Share by Regions (2013-2018)
4.1.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Regions (2013-2018)
4.2 North America Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
4.3 Europe Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
4.5 South America Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
5 North America Equine Pharmaceuticals and Supplements by Countries
5.1 North America Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Countries
5.1.1 North America Equine Pharmaceuticals and Supplements Sales and Market Share by Countries (2013-2018)
5.1.2 North America Equine Pharmaceuticals and Supplements Revenue and Market Share by Countries (2013-2018)
5.2 United States Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
5.3 Canada Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
5.4 Mexico Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
6 Europe Equine Pharmaceuticals and Supplements by Countries
6.1 Europe Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Countries
6.1.1 Europe Equine Pharmaceuticals and Supplements Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Equine Pharmaceuticals and Supplements Revenue and Market Share by Countries (2013-2018)
6.2 Germany Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
6.3 UK Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
6.4 France Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
6.5 Russia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
6.6 Italy Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
7 Asia-Pacific Equine Pharmaceuticals and Supplements by Countries
7.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Equine Pharmaceuticals and Supplements Revenue and Market Share by Countries (2013-2018)
7.2 China Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
7.3 Japan Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
7.4 Korea Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
7.5 India Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
8 South America Equine Pharmaceuticals and Supplements by Countries
8.1 South America Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Countries
8.1.1 South America Equine Pharmaceuticals and Supplements Sales and Market Share by Countries (2013-2018)
8.1.2 South America Equine Pharmaceuticals and Supplements Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
8.3 Argentina Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
8.4 Colombia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
9 Middle East and Africa Equine Pharmaceuticals and Supplements by Countries
9.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
9.3 UAE Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
9.4 Egypt Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
9.5 Nigeria Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
9.6 South Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
10 Global Equine Pharmaceuticals and Supplements Market Segment by Type
10.1 Global Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Equine Pharmaceuticals and Supplements Sales and Market Share by Type (2013-2018)
10.1.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Type (2013-2018)
10.2 Pharmaceuticals Sales Growth and Price
10.2.1 Global Pharmaceuticals Sales Growth (2013-2018)
10.2.2 Global Pharmaceuticals Price (2013-2018)
10.3 Supplements Sales Growth and Price
10.3.1 Global Supplements Sales Growth (2013-2018)
10.3.2 Global Supplements Price (2013-2018)
11 Global Equine Pharmaceuticals and Supplements Market Segment by Application
11.1 Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2013-2018)
11.2 Veterinary Hospitals Sales Growth (2013-2018)
11.3 Drug Stores Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Equine Pharmaceuticals and Supplements Market Forecast (2018-2023)
12.1 Global Equine Pharmaceuticals and Supplements Sales, Revenue and Growth Rate (2018-2023)
12.2 Equine Pharmaceuticals and Supplements Market Forecast by Regions (2018-2023)
12.2.1 North America Equine Pharmaceuticals and Supplements Market Forecast (2018-2023)
12.2.2 Europe Equine Pharmaceuticals and Supplements Market Forecast (2018-2023)
12.2.3 Asia-Pacific Equine Pharmaceuticals and Supplements Market Forecast (2018-2023)
12.2.4 South America Equine Pharmaceuticals and Supplements Market Forecast (2018-2023)
12.2.5 Middle East and Africa Equine Pharmaceuticals and Supplements Market Forecast (2018-2023)
12.3 Equine Pharmaceuticals and Supplements Market Forecast by Type (2018-2023)
12.3.1 Global Equine Pharmaceuticals and Supplements Sales Forecast by Type (2018-2023)
12.3.2 Global Equine Pharmaceuticals and Supplements Market Share Forecast by Type (2018-2023)
12.4 Equine Pharmaceuticals and Supplements Market Forecast by Application (2018-2023)
12.4.1 Global Equine Pharmaceuticals and Supplements Sales Forecast by Application (2018-2023)
12.4.2 Global Equine Pharmaceuticals and Supplements Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Equine Pharmaceuticals and Supplements Picture
Table Product Specifications of Equine Pharmaceuticals and Supplements
Figure Global Sales Market Share of Equine Phar
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
